Delivery Order 75N91021D00001-75N91023F00002
Award Date 7/19/23
Potential Completion Date 7/18/24
Potential Value $63K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $20,481 purchase order to Olink Proteomics Inc. of Waltham, Massachusetts for biological products and services. The firm fixed price contract runs from November 13, 2023 through December 26, 2023 and will support the NIH NCI's research efforts. No subcontractors or set aside designations were identified. Olink Proteomics will provide biological materials to aid the NIH NCI in...
- Olink Proteomics AB was awarded a $78,190 firm fixed price delivery order by the National Cancer Institute, a component of the Department of Health and Human Services, to provide services evaluating circulating biomarkers in cancer. The delivery order was issued under an indefinite delivery/indefinite quantity contract vehicle to support the Division of Cancer Epidemiology and Genetics. Services will include evaluating circulating biomarkers to support the Division's research efforts....
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $51,660 firm fixed price delivery order to Olink Proteomics AB of Watertown, Massachusetts. The order is for services to evaluate circulating biomarkers in cancer in support of the Division of Cancer Epidemiology and Genetics. The award has a period of performance through February 4, 2022. No set-aside provisions were applied to this order issued under an unspecified preexisting contract...
- Olink Proteomics AB has been awarded a $10,078.96 purchase order by the National Institutes of Health's National Cancer Institute to provide biological and reagent materials for direct use. The firm fixed price contract runs from November 29, 2023 through December 31, 2023 and will be performed in Waltham, Massachusetts. No major subcontractors or set aside designations were indicated. The materials will support the National Cancer Institute's mission to lead the National Cancer Program and...
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Olink Proteomics AB, a foreign-owned for-profit organization, to provide testing services using inflammation and cardiometabolic panels. The contract has a period of performance from May 1, 2018 to April 30, 2019 and a firm fixed price contract value of $157,489.90. No set-aside designation was indicated. Olink Proteomics AB has provided similar proteomics analysis...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $50,688 firm fixed price delivery order to Olink Proteomics AB of Waltham, Massachusetts. The order is for Olink Target-96 Immuno-Oncology Analysis Service in support of the agency's Center for Immunology-Oncology programs. Performance will take place in Waltham from August 1, 2023 through January 31, 2024. No subcontractors or set aside designations were indicated. The delivery order...
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a $97,210 firm fixed price purchase order to Olink Proteomics Inc. to deliver one Olink Signature Q100 instrument and associated accessories in support of proteomics research at the Center for Cancer Research, Center for Immuno-Oncology. Per the original solicitation, the acquisition is for the instrument, accessories, delivery, installation if required, and after-sales...
- This firm-fixed-price purchase order was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $13,184 contract is for a service agreement with a completion date of September 21, 2025. Olink Proteomics provides a range of proteomics instruments, reagent kits, integrated fluidic circuits, analysis services, and biological products to support biomedical...
- Olink Proteomics AB was awarded a $31,130 firm fixed price delivery order against an unspecified contract vehicle to provide OLINK 1536 analysis services in support of the National Cancer Institute's Pediatric Oncology Branch programs. The services will be performed in Waltham, Massachusetts with work expected to be completed by December 16, 2022. The award was made by the Department of Health and Human Services' National Institutes of Health National Cancer Institute on December 15, 2021...
- Olink Proteomics AB was awarded a firm fixed price, indefinite delivery contract valued at up to $1,214,788 by the National Institutes of Health National Institute on Drug Abuse to provide biological and reagent materials as well as proteomics analysis services. Specializing in proprietary multiplex protein biomarker analysis technologies, Olink will support biomedical research efforts through delivery of Olink Explore and Target multiplex protein analysis kits, reagents, array chips, and...